Primary Site >> Colorectal Cancer
Gene >> CDH3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Functional loss of E-cadherin and cadherin-11 alleles on chromosome 16q22 in colonic cancer. PMID: 10398117 |
Ref: [New oral anticancer drug, TS-1 (S-1)--from bench to clinic]. PMID: 11432358 |
Ref: Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells. PMID: 12203117 |
Ref: [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept]. PMID: 16897967 |
Ref: Pilot study of simplified low-dose S-1 plus CPT-11 as first-line chemotherapy for patients with advanced colorectal cancer. PMID: 17595792 |
Ref: High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1. PMID: 18309485 Ref: Successful treatment with S-1 plus CPT-11 for lymph node metastasis from colon cancer: report of a case. PMID: 18383902 Ref: Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo. PMID: 18829530 Ref: Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. PMID: 18927117 Ref: Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers. PMID: 18927288 |
Ref: Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer. PMID: 19528483 Ref: Frequent CDH3 demethylation in advanced gastric carcinoma. PMID: 19846933 Ref: Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. PMID: 19915572 |
Ref: Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor. PMID: 20087348 Ref: [Pharmacokinetic study of S-1 for the treatment of peritoneal metastasis from colon cancer--using a mouse peritoneal metastasis model]. PMID: 20841935 |
Ref: Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes. PMID: 21531788 |
Ref: In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy. PMID: 22223257 |
Ref: Identification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions. PMID: 23682078 |
Ref: Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. PMID: 24691442 |
Ref: Expression changes of cell-cell adhesion-related genes in colorectal tumors. PMID: 26137091 Ref: Expression Level of Genes Coding for Cell Adhesion Molecules of Cadherin Group in Colorectal Cancer Patients. PMID: 26167814 |
Ref: Filtered selection coupled with support vector machines generate a functionally relevant prediction model for colorectal cancer. PMID: 27330311 |
Ref: Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study. PMID: 27745870 Ref: P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a serum marker for colorectal cancer monitoring. PMID: 29142905 |